BioNTech SE (BNTX) — Technical state
As of 2026-11-13 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 35 out of 100 (momentum 41 · quality 22 · valuation 54), as of 2026-11-17.
- Signal: Death cross — Its 50-day crossed below its 200-day 10 sessions ago — a death cross, the classic trend-turn-lower. (as of 2026-11-13)
- Trend: BioNTech SE trades 8.0% below its 50-day and 10.6% below its 200-day moving average. (as of 2026-11-13)
- Index seat: Euro-AI 50
BioNTech develops immunotherapies, best known for its mRNA-based vaccine against SARS-CoV-2. It also runs a broad oncology pipeline spanning lung, breast, colorectal and other solid tumours, alongside infectious-disease candidates for influenza, tuberculosis and malaria.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the BNTX overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Its 50-day crossed below its 200-day 10 sessions ago — a death cross, the classic trend-turn-lower.
The moving-average stack
- vs 20-day-2.7%
- vs 50-day-8%
- vs 200-day-10.6%
- 52-week band31% off the high · +7.6% off the low
- Streak1 consecutive up session
- CrossoverDeath cross 10 sessions ago
- Stochastic%K 21.5 · %D 27.2 · down cross
Continue: the BNTX chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-13
Quick answers
What is the current Closelooknet signal on BNTX?
Death cross — Its 50-day crossed below its 200-day 10 sessions ago — a death cross, the classic trend-turn-lower. As of 2026-11-13; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is BNTX above its 50-day and 200-day moving averages?
As of 2026-11-13, BioNTech SE trades -8% below its 50-day and -10.6% below its 200-day average, with the 20-day -2.7% away.
How far is BNTX from its 52-week high?
31% below the 52-week high and 7.6% above the 52-week low, as of 2026-11-13.
Related in the Closelooknet universe
same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ASML.AS ASML Holding N.V.
- TEMN.SW Temenos Group AG
- SAN.PA Sanofi SA
- WKL.AS Wolters Kluwer N.V.
- CEVI.ST CellaVision AB
- REL.L Relx PLC
- SECT-B.ST Sectra AB (publ)
- DSY.PA Dassault Systemes SE
- HEXA-B.ST Hexagon AB (publ)
- OXIG.L Oxford Instruments PLC
- ATCO-A.ST Atlas Copco AB Series A
- LR.PA Legrand SA
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- PTGX Protagonist Therapeutics Incindustry
- BION.SW BB Biotech AGindustry
- REPL Replimune Group Incindustry
- VCEL Vericel Corp Ordindustry